SANOFI-AVENTIS (EPA:SAN) | Finanzwire

Basculer en Français

10478	Companies
220697	Keywords
149985	Articles
116699	Press releases

Home
Companies
SANOFI-AVENTIS

BRIEF

published on 05/28/2026 at 07:05, 4 days 4 hours ago

Sanofi's venglustat under priority review by the FDA for type 3 Gaucher disease

FDA Sanofi Venglustat Gaucher's Disease Priority Examination
BRIEF

published on 05/28/2026 at 07:05, 4 days 4 hours ago

Sanofi's Venglustat Granted Priority Review for Type 3 Gaucher Disease

Sanofi FDA Review Venglustat Gaucher Disease Neurological Treatment
PRESS RELEASE

published on 05/28/2026 at 07:00, 4 days 4 hours ago

Press Release: Sanofi’s venglustat accepted for priority review in the US to treat type 3 Gaucher disease
Sanofi's venglustat granted priority review by FDA for treating type 3 Gaucher disease. Potential first US therapy for neurological manifestations with target action date on November 25, 2026

FDA Sanofi Venglustat Gaucher Disease Neurological Manifestations
BRIEF

published on 05/19/2026 at 18:42, 12 days 16 hours ago

Sanofi Reports Voting Rights and Share Information for April 2026

Voting Rights French Commercial Code Shares Sanofi April 2026
PRESS RELEASE

published on 05/19/2026 at 18:37, 12 days 16 hours ago

Sanofi: Information concerning the total number of voting rights and shares - April 2026
Sanofi discloses total voting rights and shares information as per French Commercial Code and French stock market authority regulations

French Commercial Code Total Voting Rights Shares Information Sanofi Stock Market Authority
BRIEF

published on 05/18/2026 at 21:35, 13 days 13 hours ago

Sanofi announces the superiority of efdoralprin alfa in the treatment of DAAT

Sanofi Phase 2 DAAT Efdoralprin Alfa Recombinant Treatment
PRESS RELEASE

published on 05/18/2026 at 21:30, 13 days 14 hours ago

Press Release: ATS: phase 2 data demonstrate the superiority of efdoralprin alfa over a standard-of-care augmentation therapy in achieving higher fAAT levels in AATD
ElevAATe phase 2 study shows efdoralprin alfa surpassing traditional therapy in achieving and maintaining fAAT levels in AATD patients with emphysema. Results presented at 2026 ATS International Conference

Efdoralprin Alfa ElevAATe FAAT Levels AATD Emphysema
BRIEF

published on 04/24/2026 at 20:35, 1 month 6 days ago

Sanofi Prices €2.3 Billion in Bond Offering

Corporate Finance Bond Issue Sanofi Fixed-rate Notes Euro Medium Term Note
PRESS RELEASE

published on 04/24/2026 at 20:30, 1 month 6 days ago

Press Release: Sanofi successfully prices 2.3 billion of bond issue
Sanofi successfully prices €2.3 billion bond issue with notes across 3 tranches under Euro Medium Term Note programme. Net proceeds for general corporate purposes

Bond Issue Corporate Purposes Sanofi Euro Medium Term Note Global Coordinators
BRIEF

published on 04/24/2026 at 12:14, 1 month 6 days ago

Sanofi receives a favorable opinion for tolebrutinib in the treatment of multiple sclerosis

Multiple Sclerosis Approval Sanofi Tolebrutinib CMUH

Accesswire

Published on 06/01/2026 at 09:05, 2 hours 27 minutes ago

Nano One Announces Retirement of Founder and CEO Dan Blondal, President & Chief Strategy Officer Alex Holmes Appointed to CEO Role
Published on 06/01/2026 at 08:00, 3 hours 32 minutes ago

Grande Portage Resources Advances Ongoing Project Studies and Fieldwork to Support New Amalga Gold Project Development
Published on 05/30/2026 at 04:00, 2 days 7 hours ago

Vanta Announces Strategic Private Placement Financing to Advance U.S. Peptide Market Entry and Integrated Longevity and Consumer Health Sciences Platform
Published on 05/30/2026 at 02:40, 2 days 8 hours ago

BEACN Announces Financial Results for the First Quarter of 2026 and Update on Loan
Published on 05/30/2026 at 01:30, 2 days 10 hours ago

Core Critical Approved for Listing on OTCQB(R) Venture Market

View all ACCESSWIRE

EQS Group

Published on 06/01/2026 at 11:18, 14 minutes ago

Aroundtown SA: Release of a capital market information
Published on 06/01/2026 at 11:17, 15 minutes ago

Custodian Property Income REIT plc: Total Voting Rights
Published on 06/01/2026 at 11:00, 32 minutes ago

Haier Launches Horizon Refrigerator in Vietnam, Setting New Standards for Freshness and Home Appliance Design
Published on 06/01/2026 at 11:00, 32 minutes ago

REPLOID sees significant potential for food retail and food industry regarding end-of-waste status under the waste management act — reducing scope 3 emissions and optimizing costs
Published on 06/01/2026 at 10:47, 45 minutes ago

Original-Research: The Platform Group SE & Co. KGaA (von First Berlin Equity Research GmbH): Buy

Les Echos

Published on 06/01/2026 at 08:01, 3 hours 31 minutes ago

Saint-Gobain divests HKO, a high-temperature industrial insulation textile business
Published on 06/01/2026 at 06:59, 4 hours 33 minutes ago

OPmobility and Yanfeng finalize the strengthening of their Chinese joint venture YFPO
Published on 05/29/2026 at 22:00, 2 days 13 hours ago

Information on the Annual Financial Statements 2025
Published on 05/29/2026 at 18:00, 2 days 17 hours ago

Recticel Group acquires Isopanel NV to deliver integrated solutions in the cold storage panels market
Published on 05/29/2026 at 17:52, 2 days 17 hours ago

Share buyback mandate

View all LES ECHOS COMFI WIRE